Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Cerilliant
Deloitte
UBS
Healthtrust
Citi
Mallinckrodt
Boehringer Ingelheim

Generated: January 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Reslizumab

« Back to Dashboard

US Patents for Reslizumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Reslizumab ➤ Try a Free Trial Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders Knopp Biosciences LLC (Pittsburgh, PA) ➤ Try a Free Trial
Reslizumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Reslizumab ➤ Try a Free Trial Stabilizing alkylglycoside compositions and methods thereof Aegis Therapeutics LLC (San Diego, CA) ➤ Try a Free Trial
Reslizumab ➤ Try a Free Trial Stabilizing alkylglycoside compositions and methods thereof Aegis Therapeutics, LLC (San Diego, CA) ➤ Try a Free Trial
Reslizumab ➤ Try a Free Trial Pyrimidyl cyclopentanes as AKT protein kinase inhibitors Array BioPharma, Inc. (Boulder, CO) Genentech, Inc. (South San Francisco, CA) ➤ Try a Free Trial
Reslizumab ➤ Try a Free Trial Antibodies with enhanced or suppressed effector function Zymeworks Inc. (Vancouver, British Columbia, CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Reslizumab

Drugname Country Document Number Estimated Expiration Related US Patent
Reslizumab Australia 2014287067 2033-07-12 ➤ Try a Free Trial
Reslizumab Australia 2014306597 2033-07-12 ➤ Try a Free Trial
Reslizumab Australia 2014306683 2033-07-12 ➤ Try a Free Trial
Reslizumab Australia 2017276231 2033-07-12 ➤ Try a Free Trial
Reslizumab Canada 2918035 2033-07-12 ➤ Try a Free Trial
Reslizumab Canada 2921378 2033-07-12 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Daiichi Sankyo
Argus Health
US Army
Cerilliant
Julphar
Colorcon
Cipla
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.